These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 9019169

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A, Gold LI, Wang J, Cohen A, Friedman E.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [Abstract] [Full Text] [Related]

  • 3. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK.
    Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M, Oyasu R.
    Cell Growth Differ; 1997 Aug 15; 8(8):921-6. PubMed ID: 9269901
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.
    Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181
    [Abstract] [Full Text] [Related]

  • 8. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

  • 9. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
    Wu SP, Sun LZ, Willson JK, Humphrey L, Kerbel R, Brattain MG.
    Cell Growth Differ; 1993 Feb 28; 4(2):115-23. PubMed ID: 8494782
    [Abstract] [Full Text] [Related]

  • 10. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK, Earp HS, Russell WE, Smith GJ, Grisham JW.
    Cell Growth Differ; 1995 Mar 28; 6(3):251-61. PubMed ID: 7794793
    [Abstract] [Full Text] [Related]

  • 11. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 12. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.
    Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells.
    Shimizu S, Nishikawa Y, Kuroda K, Takagi S, Kozaki K, Hyuga S, Saga S, Matsuyama M.
    Cancer Res; 1996 Jul 15; 56(14):3366-70. PubMed ID: 8764135
    [Abstract] [Full Text] [Related]

  • 15. Regulation of autocrine gastrin expression by the TGF alpha autocrine loop.
    Howell GM, Ziober BL, Humphrey LE, Willson JK, Sun L, Lynch M, Brattain MG.
    J Cell Physiol; 1995 Feb 15; 162(2):256-65. PubMed ID: 7822434
    [Abstract] [Full Text] [Related]

  • 16. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 17. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K, Krüger-Krasagakes S, Fimmel S, Eberle J, Thölke D, von der Ohe M, Mansmann U, Orfanos CE.
    J Cell Physiol; 1999 Feb 15; 178(2):179-87. PubMed ID: 10048582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM, Providence KM, Higgins PJ.
    Cell Motil Cytoskeleton; 2001 Mar 15; 48(3):163-74. PubMed ID: 11223948
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.